Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 2 from your keywords: subject="Drug Combination"
cover
Evaluation of Drugs Dose Combination for Breast Cancer in MDA-MB-231 Spheroid…
Comment Share
Karyn Tjahyadi

Triple negative breast cancer is a subtypes of breast cancer that are known to have a bad prognosis and spread faster. TNBC tends to have bad prognosis due to the absence of the ER, PR, and HER receptors on the surface of the cells. These absent of receptor cause a limitation for treating them, Additionally, several drugs were proposed as a treatment for TNBC but administration of a single drug…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
BM 23-032
cover
Validating hit genes from CRISPR screening on response toward combinations of…
Comment Share
Deanna Hannah Maringka

Acute myeloid leukemia (AML) is a heterogenous blood cancer disease that develops from the stem cell precursors which the myeloid lineage happened due to genetic lesion that leads to overproduction and failure to differentiate these myeloid blast cells. A mutation in the FMS-like tyrosine kinase 3 (FLT3) gene, is the most frequent genetic lesion in AML patients, this mutation is linked with a p…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
BM 23-031